Previsioni

Non sono disponibili dati degli analisti per questa azienda.

Notizie Vai al feed delle notizie

Vext closes Ohio branch after probe into health incidents

Vext voluntarily closes its dispensary "Herbal Wellness Center" in Jackson, Ohio, at the request of the Ohio Division of Cannabis Control (DCC) amid investigations into two serious health incidents. The company reports no conclusive evidence that Vext products caused the incidents, has provided product samples for independent testing, and has proactively quarantined certain product lines. The other five dispensaries and the cultivation facility in Ohio remain operational; Vext is cooperating with the DCC and will publish results as they become available. » Altro su de.investing.com
Vext Science increases margins and EBITDA in Q2 2026 despite revenue decline

Vext Science reported Q2 2026 revenue of $12.1 million (‑10% year on year), with a significantly higher gross margin of 55% and adjusted EBITDA of $3.4 million. Net loss fell to $0.3 million and gross profit rose to $6.7 million, supported by a stronger retail mix and better harvest yields in Ohio. The company is reducing cultivation in Arizona in favor of purchases and continues to focus on growth in Ohio, debt reduction and inventory conversion. The stock reacted positively, rising to $0.28; analysts expect profitability for the year. » Altro su de.investing.com
Vext Science reports Q3 revenue jump of 41% to 12.7 million USD

Vext Science increased revenue in the third quarter of 2025 by 41% to 12.7 million USD and recorded adjusted EBITDA of 2.1 million USD (margin 16.7%). The growth is attributed to expansions in Ohio and operational efficiency improvements in Arizona; the company plans eight dispensing locations in Ohio by 2026. Operating cash flow was 1.26 million USD, cash on hand stood at 3.7 million USD, and the stock rose 6.25% after the results. Vext Science expects improvements in revenue, adjusted EBITDA and cash flow for Q4, but sees risks from market saturation in Arizona and cross-regional price pressure. » Altro su de.investing.com

Dati finanziari dell'azienda

Nell'ultimo trimestre, Vext Science ha registrato ricavi pari a 10,35 Mln € e un utile netto di -269K €

(EUR)	giugno 2026	YoY
Ricavi	10,35 Mln	8,99%
Utile lordo	1,54 Mln	62,63%
Utile netto	-269K	78,55%
EBITDA	1,9 Mln	57,84%

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	40,4 Mln €
Numero di azioni	247,68 Mln
Massimo/minimo a 52 settimane	0,28 € - 0,0871 €
Dividendi	No
Beta	0,80
Rapporto P/E	-2,56
Rapporto PEG	-0,44
Rapporto P/B	0,86
Rapporto P/S	0,92

Profilo aziendale

Vext Science, Inc. ist über seine Tochtergesellschaften als integriertes Unternehmen für Agrartechnologie, Dienstleistungen und Immobilienverwaltung in der Cannabisbranche in den Vereinigten Staaten tätig. Das Unternehmen befasst sich mit dem Anbau, der Extraktion, der Herstellung und dem Verkauf von THC- und CBD-Patronen, Konzentraten und Esswaren. Darüber hinaus ist das Unternehmen im Einzelhandel und im Großhandel mit THC- und CBD-Produkten aus Cannabis und Hanf unter den Marken Vapen und Pure Touch Botanicals tätig. Darüber hinaus bietet das Unternehmen unter der Marke Vapen Kitchens Vapen Clear Infused Products, THC-Schokoriegel, THC-Sirup, THC-Snacks, Bonbons und Gummibärchen an. Das Unternehmen war früher als Vapen MJ Ventures Corporation bekannt und änderte im November 2019 seinen Namen in Vext Science, Inc. Vext Science, Inc. wurde im Jahr 2015 gegründet und hat seinen Hauptsitz in Phoenix, Arizona.